| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Deschatelets Pascal69 | Chief Scientific Officer | Sell | 1,148 | $67.77 | $77,796.40 | -0.1% | -36.5% | -57.9% | |
| Feb 12, 2024 | Delong Mark Jeffrey76 | Chief Business &Strat Officer | Sell | 597 | $67.77 | $40,456.84 | -0.9% | -36.5% | -57.9% | |
| Jan 30, 2024 | Lewis Karen76 | Chief People Officer | Sell | 1,250 | $65.12 | $81,401.71 | -1.3% | -27.5% | -55.3% | |
| Jan 30, 2024 | Eisele Jeffrey76 | Chief Development Officer | Sell | 1,250 | $65.22 | $81,524.19 | -1.1% | -27.5% | -55.3% | |
| Jan 29, 2024 | Watson David O.70 | General Counsel | Sell | 906 | $64.14 | $58,109.21 | -0.9% | -26.8% | -55.2% | |
| Jan 29, 2024 | Townsend Adam J.74 | Chief Commercial Officer | Sell | 906 | $64.14 | $58,109.21 | -1.0% | -26.8% | -55.2% | |
| Jan 29, 2024 | Sullivan Timothy Eugene85 | Chief Financial Officer | Sell | 906 | $64.14 | $58,109.21 | -0.9% | -26.8% | -55.2% | |
| Jan 29, 2024 | Nicholson Nur82 | Chief Technical Officer | Sell | 835 | $64.14 | $53,555.40 | -1.2% | -26.8% | -55.2% | |
| Jan 29, 2024 | Francois Cedric78 | Chief Executive Officer | Sell | 2,843 | $64.14 | $182,344.90 | -0.9% | -26.8% | -55.2% | |
| Jan 29, 2024 | Deschatelets Pascal69 | Chief Scientific Officer | Sell | 874 | $64.14 | $56,056.79 | - | -26.8% | -55.2% |